341 lines
21 KiB
HTML
341 lines
21 KiB
HTML
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
|
|
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
|
<html xmlns="http://www.w3.org/1999/xhtml">
|
|
<head>
|
|
<title>Treatment of Common Non-Cancerous Uterine Conditions</title>
|
|
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
|
|
<!-- "metadata" -->
|
|
<meta name="description" content="Highlights of a 1994 conference on research issues in the
|
|
effectiveness of hysterectomy and alternative therapies for common non-cancerous uterine
|
|
conditions." />
|
|
<meta name="keywords" content="Agency for Health Care Policy and Research, Agency for Healthcare Research and Quality, AHRQ, AHCPR, access, adolescent, asthma, child, CHIPRA, chronic care, diabetes, disability, disparities, elderly, end of life, Hispanic, infants, inner city, kidney, long-term care, low income, men's health, minority health, neonatal, nursing homes, rural, senior, specific populations, teens, women, women's health" />
|
|
<!-- end metadata -->
|
|
<link href="/includes/archive.css" rel="stylesheet" type="text/css" />
|
|
<link href="/includes/ahrqstyleprint_arch.css" rel="stylesheet" type="text/css" media="print" />
|
|
<script>
|
|
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
|
|
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
|
|
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
|
|
})(window,document,'script','//www.google-analytics.com/analytics.js','ga');
|
|
|
|
ga('create', 'UA-75759936-1', 'auto');
|
|
ga(' set', 'anonymizeIp', true);
|
|
|
|
ga('send', 'pageview');
|
|
|
|
</script></head><body><!-- Google Tag Manager -->
|
|
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-W4DST4"
|
|
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
|
|
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
|
|
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
|
|
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
|
|
'//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
|
|
})(window,document,'script','dataLayer','GTM-W4DST4');</script>
|
|
<!-- End Google Tag Manager -->
|
|
<noscript>
|
|
Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
|
|
</noscript>
|
|
|
|
<!-- Page Header v2.0 -->
|
|
<a name="top" id="top"></a>
|
|
<!--Begin Banner CodeS-->
|
|
<div id="ahrqbanner">
|
|
<div class="hhsportion">
|
|
<a href="#h1" class="skipnav">Skip Navigation</a>
|
|
<a href="http://www.hhs.gov" title="U.S. Department of Health and Human Services">
|
|
<img src="/images/hhs_banner.gif" alt="U.S. Department of Health and Human Services" />
|
|
</a>
|
|
<a href="http://www.hhs.gov" title="www.hhs.gov" class="hhsright">
|
|
<img src="/images/hhs_link.gif" alt="www.hhs.gov" />
|
|
</a>
|
|
</div>
|
|
|
|
<div class="ahrqportion">
|
|
<a href="/" title="Archive: Agency for Healthcare Research Quality">
|
|
<img src="/images/ahrq_banner.gif" alt="Agency for Healthcare Research Quality" />
|
|
</a><form name="searchForm" method="get" action="https://search.ahrq.gov/search" id="banner_searchform">
|
|
<label for="search" style="z-index:-1;position:relative;margin-right:-65px; font-size:0px;">Search</label>
|
|
<input name="q" type="text" value=" Search Archive" size="11" onfocus="this.value='';" class="gotext" label="Search archive" id="search" />
|
|
<input type="hidden" name="entqr" value="0" />
|
|
<input type="hidden" name="output" value="xml_no_dtd" />
|
|
<input type="hidden" name="proxystylesheet" value="ARCHIVE_Front_End" />
|
|
<input type="hidden" name="client" value="ARCHIVE_Front_End" />
|
|
<input type="hidden" name="site" value="ARCHIVE_AHRQ_GOV" />
|
|
<input src="/images/topbn_GoButton.gif" class="gobtn" name="Submit" onclick="javascript:document.searchForm.submit();" type="image" alt="Search" />
|
|
</form>
|
|
<a href="https://www.ahrq.gov/" class="ahrqright">www.ahrq.gov</a>
|
|
</div><div class="ahrqlinks"><a href="https://www.ahrq.gov/">AHRQ Home—Live Site</a> | <a href="/">Archive Home</a> | <a href="/sitemap.htm">Site Map</a> <!-- | <img src="/images/envelope1.jpg" alt="" width="21" height="14" /><a href="https://subscriptions.ahrq.gov/service/multi_subscribe.html?code=USAHRQ">E-mail Updates</a> --></div>
|
|
</div>
|
|
<div id="PrintBanner">
|
|
<img src="/images/printbanner_arch.jpg" alt="Archive print banner" />
|
|
</div>
|
|
<a name="h1"></a>
|
|
<!-- End banner code -->
|
|
<!-- End of Page header -->
|
|
|
|
<!-- Content Body -->
|
|
<div id="mainContent">
|
|
<table width="100%" border="0" cellspacing="0" cellpadding="0" >
|
|
<tr valign="top">
|
|
<td width="70%">
|
|
<!-- Center Content section -->
|
|
<table width="100%" border="0" cellpadding="0" cellspacing="0" style="margin-left:10px; margin-right:10px;margin-top:5px" summary="This table gives the layout format of the bread crumb area and the center content area.">
|
|
<!--DWLayoutTable-->
|
|
<tr>
|
|
<td class="crumb_link"><div id="crumbContent">
|
|
<p><strong>You Are Here:</strong> <span class="crumb_link"><a href="/" class="crumb_link">AHRQ Archive Home</a> > <a href="/research/womenarch.htm" class="crumb_link">Women's Health Archive</a> > Treatment of Common Non-Cancerous Uterine Conditions</span></p>
|
|
</div>
|
|
</td>
|
|
</tr>
|
|
<tr>
|
|
<td><h1><a name="h1" id="h1"></a> Treatment of Common Non-Cancerous Uterine Conditions</h1>
|
|
</td>
|
|
</tr>
|
|
<tr>
|
|
<td><div id="centerContent"><div class="headnote">
|
|
<p>This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: <a href="https://info.ahrq.gov/">https://info.ahrq.gov</a>. Let us know the nature of the problem, the Web address of what you want, and your contact information. </p>
|
|
|
|
|
|
<p>Please go to <a href="https://www.ahrq.gov/">www.ahrq.gov</a> for current information.</p></div>
|
|
<h2>Issues for Research</h2>
|
|
<h3>Conference Summary</h3>
|
|
<hr />
|
|
<p> Following are highlights of a May 1994 AHCPR conference on research issues in the
|
|
effectiveness of hysterectomy and alternative therapies for common non-cancerous uterine
|
|
conditions. The full report of the conference is available from the AHCPR Publications
|
|
Clearinghouse. Call toll free 800-358-9295. Order AHCPR Pub. No. 95-0067 (July 1995).</p>
|
|
<hr />
|
|
<h2>Overview</h2>
|
|
<p>
|
|
Hysterectomy is the most common nonpregnancy-related major surgery performed on women
|
|
in the United States. In 1995, approximately 590,000 women in this country will undergo the
|
|
procedure. Surgical removal of the uterus, and frequently the ovaries, is widely accepted both
|
|
by medical professionals and the public as appropriate treatment for uterine cancer, and for
|
|
various common non-cancerous uterine conditions that can produce often disabling levels of
|
|
pain, discomfort, uterine bleeding, emotional distress, and related symptoms. Yet, while
|
|
hysterectomy<em> can</em> alleviate uterine problems, less invasive treatments are available. </p>
|
|
<p>
|
|
Most women who undergo hysterectomy are between the ages of 35 and 54, with the highest
|
|
age-specific rate for women 35 to 44 years of age. Overall, fibroids account for approximately
|
|
one-third of all hysterectomies performed in the United States. Endometriosis is the second
|
|
most common condition leading to hysterectomy, accounting for 18 percent. Hysterectomy
|
|
rates also are correlated with a number of non-clinical characteristics of patients, such as
|
|
socioeconomic status, and with provider variables, such as physician training. </p>
|
|
<p>
|
|
Health services research findings since the 1970s have highlighted wide, unexplained
|
|
variations in rates of hysterectomy in different parts of the United States, and much higher
|
|
rates in the United States compared with other Western countries. There is no way, however,
|
|
to determine from these studies which rate is <em>right</em>. </p>
|
|
<p>
|
|
Thus, AHCPR initiated work to identify specific research opportunities related to the outcomes
|
|
of hysterectomy and its alternatives, and to encourage such research. The conference had a
|
|
dual purpose: to assess the state of the science, and to identify the most important areas for
|
|
effectiveness research. </p>
|
|
<h2>Conclusions</h2>
|
|
<p>
|
|
The current scientific literature is weak and incomplete. Studies containing original data
|
|
typically are small, observational studies; the few which compare treatments focus on one type
|
|
of hysterectomy versus another type (e.g., abdominal versus vaginal surgery). Outcomes
|
|
addressed in these studies are limited almost exclusively to traditional endpoints, such as
|
|
mortality, complications of surgery, and other physician assessments. These studies confirm
|
|
that the risk of mortality is low; however, complications are common occurrences.</p>
|
|
<p>
|
|
Very few studies provide information about the effects of hysterectomy on the symptoms that
|
|
led women to seek treatment in the first place or on the long-term outcomes that contribute to
|
|
the patient's quality of life. Reports often lack enough data about study design, sample size,
|
|
patient characteristics, reasons for treatment, and other information critical to interpreting and
|
|
weighing the results.</p>
|
|
<p>
|
|
Even the best studies beg the critical question: For non-cancerous uterine conditions, <em>what
|
|
treatment is most effective?</em> Only a few, preliminary studies have compared the outcomes of
|
|
hysterectomy with other treatment alternatives and considered outcomes from the patient's
|
|
perspective. </p>
|
|
<p>
|
|
Alternatives to hysterectomy fall into three general categories: conservative surgical
|
|
management; pharmacologic therapies (hormonal and nonhormonal); and other strategies,
|
|
including psychosocial support and therapy, and watchful waiting. There has been little
|
|
research on how physicians or their patients choose among available treatments. Potential
|
|
applications of these treatments are summarized in the following table: </p>
|
|
<h3>Alternatives to Hysterectomy for Common Non-Cancerous Uterine Conditions</h3>
|
|
<table border="1" cellpadding="2" cellspacing="0" width="99%"><thead>
|
|
<tr valign="top">
|
|
<th scope="col" rowspan="2">Condition </th>
|
|
<th scope="col" rowspan="2">Conservative Surgery</th>
|
|
<th scope="col" colspan="2">Pharmacologic Therapies</th>
|
|
<th scope="col" rowspan="2">Other Strategies</th></tr>
|
|
<tr valign="top">
|
|
<th scope="col">Hormonal</th>
|
|
<th scope="col">Nonhormonal </th>
|
|
</tr></thead><tbody>
|
|
<tr valign="top">
|
|
<td scope="row">Fibroids</td>
|
|
<td>Myomectomy<br />Endometrial ablation</td>
|
|
<td>GnRH(<a href="#a">a</a>) agonists with add-back therapy<br />Oral contraceptives<br />Androgens<br />RU-486(<a href="#b">b</a>)<br />Gestrinone(<a href="#b">b</a>)</td>
|
|
<td>NSAIDS(<a href="#c">c</a>)</td>
|
|
<td>Watchful waiting</td>
|
|
</tr><tr valign="top">
|
|
<td scope="row">Endometriosis</td>
|
|
<td>Adhesiolysis<br />Excision of endometrial ablation<br />Resection of cul-de-sac obliteration<br />Nerve blocks<br />Uterosacral nerve ablation</td>
|
|
<td>GnRH(<a href="#a">a</a>) agonists with add-back therapy<br />Danazol<br />Progestins<br />Oral contraceptives<br />Tamoxifen(<a href="#b">b</a>)<br />RU-486b </td>
|
|
<td> NSAIDS(<a href="#c">c</a>)<br />Analgesics<br />Anxiolytics</td>
|
|
<td>Watchful waiting<br />Biofeedback<br />Acupuncture<br />Hypnosis<br />Lifestyle change(nutrition, exercise)</td>
|
|
</tr><tr valign="top">
|
|
<td scope="row">Prolapse</td>
|
|
<td> Anterior or posterior colporrhaphy<br />Laparoscopic or vaginal suspension techniques </td>
|
|
<td>Estrogen</td>
|
|
<td> </td>
|
|
<td>Watchful waiting<br />Kegel exercises<br />Pessaries<br />Electrical stimulation<br />Urethral beads<br />Periurethral injections of GAX(<a href="#b">b</a>), collagen, fat, silicon, etc.
|
|
</td>
|
|
</tr><tr valign="top">
|
|
<td scope="row">Dysfunctional bleeding</td>
|
|
<td>Dilation and curettage<br />Endometrial ablation </td>
|
|
<td>Progestins<br />Estrogen<br />Oral contraceptives<br />Danazol<br />Prostaglandin inhibitors <br /> GnRH(<a href="#a">a</a>) agonists<br />Antifibrinolytic agents<br />Luteinizing hormone agonists</td>
|
|
<td> </td>
|
|
<td> Watchful waiting<br /> Antidepressants</td>
|
|
</tr><tr valign="top">
|
|
<td scope="row">Chronic pelvic pain </td>
|
|
<td>Adhesiolysis<br />Nerve blocks<br />Denervation procedure <br />Uterosacral nerve ablation</td>
|
|
<td>Danazol<br />GnRH(<a href="#a">a</a>) agonists with add-back therapy<br />Oral contraceptives<br />Medroxyprogesterone acetate</td>
|
|
<td>NSAIDs(<a href="#c">c</a>)<br /> Analgesics<br />Nerve blocks<br />Narcotics </td>
|
|
<td>Watchful waiting<br /> Counseling<br /> Biofeedback<br /> Relaxation techniques<br /> Trigger point injections<br /> Acupuncture<br /> Psychotropics<br /> Antidepressants<br /> Physical therapy</td>
|
|
</tr>
|
|
</tbody></table>
|
|
|
|
|
|
<p class="size2"><strong>Notes:</strong><br />
|
|
<a name="a"></a>(a) Gonadotropin-releasing hormone.<br />
|
|
<a name="b"></a>(b) Experimental treatment.<br />
|
|
<a name="c"></a>(c) Nonsteroidal anti-inflammatory drugs.</p>
|
|
<p>
|
|
The research needs identified by AHCPR's conferees address the scarcity of attempts to prove
|
|
the effectiveness of hysterectomy, the methodological weaknesses in much of the clinical
|
|
research that has been done, and the limited attention to outcomes important to patients. </p>
|
|
<p>
|
|
AHCPR is particularly interested in supporting randomized clinical trials designed to answer
|
|
important questions about effectiveness and relative effectiveness. Studies addressing related
|
|
issues, such as methodological and epidemiological topics, also are encouraged as appropriate
|
|
submissions for AHCPR's program of research on medical effectiveness.</p>
|
|
<h2>Research Recommendations </h2>
|
|
<p>
|
|
All Non-Cancerous Uterine Conditions:</p>
|
|
<ul>
|
|
<li>Evidence regarding the effectiveness and relative effectiveness of hysterectomy and
|
|
alternative treatments is seriously lacking. Prospective randomized studies are needed
|
|
comparing hysterectomy with watchful waiting, and comparing different treatment
|
|
strategies (surgical, pharmacologic, psychological, and combinations thereof). </li>
|
|
<li>A broad range of patient outcomes need assessment. Typically, symptoms are what drive
|
|
women to treatment for non-cancerous uterine conditions. Thus, in addition to traditional
|
|
clinical endpoints, it is critical to understand the effects of treatment (or time) on the
|
|
presenting symptoms and development of new symptoms, and to measure the value of
|
|
particular outcomes to individual women. </li>
|
|
|
|
<li>Assessment of multiple outcomes require basic methodological work to validate existing
|
|
measures or develop new measures. Measures need to be validated and standardized so that
|
|
the findings of different studies can be compared and, possibly, to permit aggregation of
|
|
results from small studies.</li>
|
|
|
|
<li>Epidemiologic studies, especially large, prospective, community-based cohort studies, are
|
|
needed to determine the incidence and prevalence of uterine problems, their natural history,
|
|
and the factors that place some women at high risk. </li>
|
|
|
|
<li>Important variables influencing patients' and providers' perceptions and expectations of
|
|
different treatments are poorly understood. Research is needed to explain how physician-patient interaction affects treatment decisions.</li>
|
|
</ul>
|
|
<p>Uterine Fibroids:</p>
|
|
<ul>
|
|
<li>Management of asymptomatic fibroids—when, if, or how to treat.</li>
|
|
<li>Importance of fibroid size. Published criteria generally recommend surgical removal of
|
|
fibroids if and when they reach the size of the uterus at 12-weeks gestation, and this has
|
|
become usual practice. Studies are needed to determine how changes in fibroid size
|
|
influence patients' functional status and quality of life. The scientific literature does not
|
|
provide adequate evidence to support the recommendation/practice of hysterectomy at 12-weeks gestational size.</li>
|
|
<li>Formation of leiomyosarcoma. With the possibility of malignant change in fibroids, rapid
|
|
growth in the size of the uterus or fibroids is often used as justification for hysterectomy.
|
|
The scientific basis for this practice is inadequate.</li>
|
|
<li>Mechanisms of hormone ablation, add-back (norethindrone) therapy, and fibroid growth in
|
|
the absence of estrogen. Investigations in hormonal therapies and management need to
|
|
address receptor content.</li>
|
|
<li>Etiology of fibroids, the mechanisms that influence their growth, and reasons for
|
|
apparently higher rates in black women relative to white women.</li>
|
|
</ul>
|
|
<p>
|
|
Endometriosis:</p>
|
|
|
|
<ul>
|
|
<li>Determine what attributes of patient, provider, and treatment predict relief of pain, cost,
|
|
health status, functional status, and health-related quality of life.</li>
|
|
<li>Develop techniques and methods that are less invasive than laparoscopy for diagnosing
|
|
endometriosis, e.g., imaging techniques and/or blood-serum markers.</li>
|
|
<li>Investigate the relationship between endometriosis and dysmenorrhea, and between
|
|
endometriosis and non-cyclic chronic pelvic pain. </li>
|
|
<li>Investigate the biologic etiology of endometriosis and how various growth factors as well
|
|
as the immune system affect the initiation and progress of the disease.</li>
|
|
</ul>
|
|
<p>
|
|
Pelvic Prolapse/Urinary Dysfunction:</p>
|
|
<ul>
|
|
<li>No scientific evidence was found favoring hysterectomy as the best alternative for
|
|
managing pelvic prolapse. In fact, the studies containing original data were all conducted in
|
|
women who experienced prolapse <em>subsequent</em> to hysterectomy. </li>
|
|
<li>For uterine prolapse, determine the effectiveness, relative to hysterectomy, of non-surgical
|
|
treatments including the use of pessaries, estrogen, and exercises to strengthen the pelvic
|
|
floor.</li>
|
|
<li>For urinary stress incontinence, determine the relative effectiveness of available treatments.
|
|
Panelists recommended a prospective clinical trial, with minimum 5-year followup, to
|
|
determine the effectiveness of surgical and nonsurgical treatments for urinary stress
|
|
incontinence. </li>
|
|
</ul>
|
|
<p>Dysfunctional Uterine Bleeding and Chronic Pelvic Pain:</p>
|
|
|
|
<ul>
|
|
<li>For dysfunctional bleeding, compare the outcomes of alternative treatments, including
|
|
medical treatments, surgical alternatives (endometrial ablation and hysterectomy), and
|
|
watchful waiting.</li>
|
|
<li>For the management of chronic pelvic pain, evaluate the effectiveness of hysterectomy,
|
|
surgical procedures other than hysterectomy (lysis of pelvic adhesions, etc.), medical
|
|
therapies (trigger point injections, etc.), and non-traditional therapies, such as biofeedback.</li>
|
|
<li>Investigate the effectiveness of imaging methods commonly used to diagnose the cause of
|
|
chronic pelvic pain. </li>
|
|
</ul>
|
|
<!-- <hr />
|
|
<p class="size2"><strong>Internet Citation:</strong></p>
|
|
<p class="size2"><em>Treatment of Common Non-Cancerous Uterine
|
|
Conditions: Issues for Research</em>. Conference Summary. AHCPR Publication No. 95-0067,
|
|
July 1995. Agency for Health Care Policy and Research, Rockville, MD.
|
|
https://www.ahrq.gov/research/uterine.htm </p>
|
|
<hr /> -->
|
|
<p> </p>
|
|
<div class="footnote">
|
|
<p> The information on this page is archived and provided for reference purposes only.</p></div>
|
|
<p> </p>
|
|
</div>
|
|
</td>
|
|
</tr>
|
|
</table>
|
|
<!-- End of Center Content section -->
|
|
</td>
|
|
</tr>
|
|
</table>
|
|
</div>
|
|
<!-- End of Content Body -->
|
|
<!-- Footer graphic 1.2-->
|
|
<table cellspacing="0" cellpadding="0" border="0" width="100%">
|
|
<tr>
|
|
<td width="125" background="/images/bottom_ahrq_bkg.jpg"><img src="/images/bottom_ahrq_1.jpg" width="125" alt="AHRQ" /></td>
|
|
<td width="100%" background="/images/bottom_ahrq_bkg.jpg" ><img src="/images/bottom_ahrq_bkg.jpg" width="10" height="34" alt="" /></td>
|
|
|
|
<td width="310" background="/images/bottom_ahrq_bkg.jpg"><img src="/images/bottom_ahrq_2.gif" alt="Advancing Excellence in Health Care" width="310" height="34" /></td>
|
|
</tr>
|
|
</table>
|
|
<!-- Footer links section -->
|
|
<div id="banner_Footer2"><p> <a href="https://www.ahrq.gov/">AHRQ Home</a> | <a href="https://info.ahrq.gov" class="footer_navlink">Questions?</a> | <a href="https://www.ahrq.gov/contact/index.html" class="footer_navlink">Contact AHRQ</a> | <a href="https://www.ahrq.gov/sitemap.html" class="footer_navlink">Site Map</a> | <a href="https://www.ahrq.gov/policy/electronic/accessibility/index.html" class="footer_navlink">Accessibility</a> | <a href="https://www.ahrq.gov/policy/electronic/privacy/index.html" class="footer_navlink">Privacy
|
|
Policy</a> | <a href="https://www.ahrq.gov/policy/foia/index.html" class="footer_navlink">Freedom of Information Act</a> | <a href="https://www.ahrq.gov/policy/electronic/disclaimers/index.html" class="footer_navlink">Disclaimers</a> | <a href="http://www.hhs.gov/open/recordsandreports/plainwritingact/index.html" class="footer_navlink">Plain Writing Act</a> <br />
|
|
|
|
<a href="http://www.hhs.gov" class="footer_navlink">U.S. Department of Health & Human Services</a> | <a href="http://www.whitehouse.gov" class="footer_navlink">The White House</a> | <a href="http://www.usa.gov" class="footer_navlink">USA.gov: The U.S. Government's Official Web Portal</a></p>
|
|
</div>
|
|
<div id="banner_Footeraddress"><p>Agency for Healthcare Research and Quality <img src="/images/bottom_dot.gif" alt="" /> 5600 Fishers Lane Rockville, MD 20857 <img src="/images/bottom_dot.gif" alt="" /> Telephone: (301) 427-1364</p></div>
|
|
|
|
<!-- End of Footer links section -->
|
|
</body>
|
|
</html>
|
|
|